GlucoTrack
GCTK
10 hedge funds and large institutions have $248K invested in GlucoTrack in 2025 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 0 closing their positions.
497% more capital invested
Capital invested by funds: $41.5K → $248K (+$206K)
25% more funds holding
Funds holding: 8 → 10 (+2)
6.32% more ownership
Funds ownership: 0.7% → 7.02% (+6.3%)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
+$272K |
| 2 |
BFM
Boothbay Fund Management
New York
|
+$80.3K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$469 |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$125 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AF
Alerus Financial
Grand Forks,
North Dakota
|
-$5.93K |
| 2 |
Morgan Stanley
New York
|
-$2.37K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.26K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
IC
1
Ikarian Capital
Dallas,
Texas
| $177K | +$272K | +45,830 | New |
|
|
BFM
2
Boothbay Fund Management
New York
| $52.3K | +$80.3K | +13,525 | New |
|
|
AF
3
Alerus Financial
Grand Forks,
North Dakota
| $15.5K | -$5.93K | -1,000 | -20% |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $1.65K | -$2.26K | -381 | -47% |
|
|
5
UBS Group
Zurich,
Switzerland
| $461 | +$469 | +79 | +198% |
|
|
NFSG
6
Newbridge Financial Services Group
Boca Raton,
Florida
| $132 | – | – | – |
|
|
7
Bank of America
Charlotte,
North Carolina
| $108 | +$125 | +21 | +300% |
|
|
SS
8
SBI Securities
Tokyo,
Japan
| $35 | – | – | – |
|
|
9
Morgan Stanley
New York
| $4 | -$2.37K | -400 | -100% |
|
10
Osaic Holdings
Scottsdale,
Arizona
| $4 | – | – | – |
|
GCTK Hedge Fund Activity: Q4 2025 in Review
10 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in GlucoTrack (GCTK) for Q4 2025, worth a combined $248K — up 497% from $41.5K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new GCTK positions and 0 closed out — a net gain of 2 holders — while 2 added to existing stakes and 3 trimmed.
The largest buyer was Ikarian Capital, opening a new position worth an estimated $272K. The largest seller was Alerus Financial, cutting an estimated $5.93K.
- 10 institutional investors held GlucoTrack (GCTK) as of Q4 2025, up from 8 in Q3 2025.
- Funds reported $248K of GlucoTrack stock for Q4 2025, up 497% quarter-over-quarter.
- 2 funds opened new GlucoTrack positions in Q4 2025 and 0 closed out, a net change of +2 holders.
- The largest GlucoTrack buyer in Q4 2025 was Ikarian Capital, an estimated $272K added.
- The largest GlucoTrack seller in Q4 2025 was Alerus Financial, an estimated $5.93K sold.
Based on aggregated 13F filings for Q4 2025.